These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19088443)

  • 1. Biophysical characterization of the short QT mutation hERG-N588K reveals a mixed gain-and loss-of-function.
    Grunnet M; Diness TG; Hansen RS; Olesen SP
    Cell Physiol Biochem; 2008; 22(5-6):611-24. PubMed ID: 19088443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N588K-HERG K+ channel mutation in the 'short QT syndrome': mechanism of gain-in-function determined at 37 degrees C.
    McPate MJ; Duncan RS; Milnes JT; Witchel HJ; Hancox JC
    Biochem Biophys Res Commun; 2005 Aug; 334(2):441-9. PubMed ID: 16011830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of I(Kr) inactivation by mutation N588K in KCNH2: a link to arrhythmogenesis in short QT syndrome.
    Cordeiro JM; Brugada R; Wu YS; Hong K; Dumaine R
    Cardiovasc Res; 2005 Aug; 67(3):498-509. PubMed ID: 16039272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of the short QT N588K mutation at 37 degrees C on hERG K+ channel current during ventricular, Purkinje fibre and atrial action potentials: an action potential clamp study.
    McPate MJ; Zhang H; Adeniran I; Cordeiro JM; Witchel HJ; Hancox JC
    J Physiol Pharmacol; 2009 Mar; 60(1):23-41. PubMed ID: 19439805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs.
    McPate MJ; Duncan RS; Hancox JC; Witchel HJ
    Br J Pharmacol; 2008 Nov; 155(6):957-66. PubMed ID: 18724381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Action potential clamp and pharmacology of the variant 1 Short QT Syndrome T618I hERG K⁺ channel.
    El Harchi A; Melgari D; Zhang YH; Zhang H; Hancox JC
    PLoS One; 2012; 7(12):e52451. PubMed ID: 23300672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HERG mutation predicts short QT based on channel kinetics but causes long QT by heterotetrameric trafficking deficiency.
    Paulussen AD; Raes A; Jongbloed RJ; Gilissen RA; Wilde AA; Snyders DJ; Smeets HJ; Aerssens J
    Cardiovasc Res; 2005 Aug; 67(3):467-75. PubMed ID: 15958262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of the β-adrenoceptor blockers carvedilol and metoprolol on SQT1- and SQT2-mutant channels.
    Bodi I; Franke G; Pantulu ND; Wu K; Perez-Feliz S; Bode C; Zehender M; zur Hausen A; Brunner M; Odening KE
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1163-71. PubMed ID: 23718892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hERG1a/1b heteromeric currents exhibit amplified attenuation of inactivation in variant 1 short QT syndrome.
    McPate MJ; Zhang H; Cordeiro JM; Dempsey CE; Witchel HJ; Hancox JC
    Biochem Biophys Res Commun; 2009 Aug; 386(1):111-7. PubMed ID: 19501051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel missense mutation causing a G487R substitution in the S2-S3 loop of human ether-à-go-go-related gene channel.
    Kinoshita K; Yamaguchi Y; Nishide K; Kimoto K; Nonobe Y; Fujita A; Asano K; Tabata T; Mori H; Inoue H; Hata Y; Fukurotani K; Nishida N
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1246-53. PubMed ID: 22764740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disopyramide is an effective inhibitor of mutant HERG K+ channels involved in variant 1 short QT syndrome.
    McPate MJ; Duncan RS; Witchel HJ; Hancox JC
    J Mol Cell Cardiol; 2006 Sep; 41(3):563-6. PubMed ID: 16842817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo effects of mutant HERG K+ channel inhibition by disopyramide in patients with a short QT-1 syndrome: a pilot study.
    Schimpf R; Veltmann C; Giustetto C; Gaita F; Borggrefe M; Wolpert C
    J Cardiovasc Electrophysiol; 2007 Nov; 18(11):1157-60. PubMed ID: 17711440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arrhythmogenesis in the short-QT syndrome associated with combined HERG channel gating defects: a simulation study.
    Itoh H; Horie M; Ito M; Imoto K
    Circ J; 2006 Apr; 70(4):502-8. PubMed ID: 16565572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased vulnerability of human ventricle to re-entrant excitation in hERG-linked variant 1 short QT syndrome.
    Adeniran I; McPate MJ; Witchel HJ; Hancox JC; Zhang H
    PLoS Comput Biol; 2011 Dec; 7(12):e1002313. PubMed ID: 22194679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation in the KCNH2 gene associated with short QT syndrome.
    Sun Y; Quan XQ; Fromme S; Cox RH; Zhang P; Zhang L; Guo D; Guo J; Patel C; Kowey PR; Yan GX
    J Mol Cell Cardiol; 2011 Mar; 50(3):433-41. PubMed ID: 21130771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and functional characterization of the novel human ether-a-go-go-related gene (hERG) R744P mutant associated with hereditary long QT syndrome 2.
    Aidery P; Kisselbach J; Gaspar H; Baldea I; Schweizer PA; Becker R; Katus HA; Thomas D
    Biochem Biophys Res Commun; 2012 Feb; 418(4):830-5. PubMed ID: 22314138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficient zebrafish ether-à-go-go-related gene channel gating causes short-QT syndrome in zebrafish reggae mutants.
    Hassel D; Scholz EP; Trano N; Friedrich O; Just S; Meder B; Weiss DL; Zitron E; Marquart S; Vogel B; Karle CA; Seemann G; Fishman MC; Katus HA; Rottbauer W
    Circulation; 2008 Feb; 117(7):866-75. PubMed ID: 18250272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant MiRP1 subunits modulate HERG K+ channel gating: a mechanism for pro-arrhythmia in long QT syndrome type 6.
    Lu Y; Mahaut-Smith MP; Huang CL; Vandenberg JI
    J Physiol; 2003 Aug; 551(Pt 1):253-62. PubMed ID: 12923204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sudden death associated with short-QT syndrome linked to mutations in HERG.
    Brugada R; Hong K; Dumaine R; Cordeiro J; Gaita F; Borggrefe M; Menendez TM; Brugada J; Pollevick GD; Wolpert C; Burashnikov E; Matsuo K; Wu YS; Guerchicoff A; Bianchi F; Giustetto C; Schimpf R; Brugada P; Antzelevitch C
    Circulation; 2004 Jan; 109(1):30-5. PubMed ID: 14676148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arrhythmic potency of human ether-a-go-go-related gene mutations L532P and N588K in a computational model of human atrial myocytes.
    Loewe A; Wilhelms M; Fischer F; Scholz EP; Dössel O; Seemann G
    Europace; 2014 Mar; 16(3):435-43. PubMed ID: 24569898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.